An alternative approach to the TRUS is the Transperineal Template Prostate Biopsy (TPTPB), and we have previously shown that TPTPB can identify clinically significant prostate cancer in 71/122 (58%) of men with raised PSA, despite two previous sets of negative TRUS biopsies (7). This evidence concerns the gene KLK3 and prostate cancer.